STOCK TITAN

MIMEDX to Host Fourth Quarter and Full Year 2023 Operating and Financial Results Conference Call on February 28

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary
MiMedx Group, Inc. (MDXG) will release its Q4 and full-year 2023 financial results on February 28, 2024. The webcast and conference call will be hosted by senior management at 4:30 p.m. ET on the same day. Investors can access the call using the provided details. A webcast replay will be available on the company's website for 30 days post-event.
Positive
  • None.
Negative
  • None.

MARIETTA, Ga., Feb. 12, 2024 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it will report its operating and financial results for the fourth quarter and full year ended December 31, 2023 after the market close on Wednesday, February 28, 2024. The MIMEDX senior management team will host a webcast and conference call to review its results beginning at 4:30 p.m. Eastern Time on the same day.

The conference call can be accessed using the following information:

Webcast: Click here
U.S. Investors: 877-407-6184
International Investors: 201-389-0877
Conference ID: 13743067

A replay of the webcast will be available for approximately 30 days on the Company’s website at www.mimedx.com following the conclusion of the event.

About MIMEDX
MIMEDX is a pioneer and leader focused on helping humans heal. With more than a decade of helping clinicians manage chronic and other hard-to-heal wounds, MIMEDX is dedicated to providing a leading portfolio of products for applications in the wound care, burn, and surgical sectors of healthcare. The Company’s vision is to be the leading global provider of healing solutions through relentless innovation to restore quality of life. For additional information, please visit www.mimedx.com.

Contact:
Matt Notarianni
Investor Relations
470-304-7291
mnotarianni@mimedx.com


FAQ

When will MiMedx Group, Inc. (MDXG) release its Q4 and full-year 2023 financial results?

MiMedx Group, Inc. (MDXG) will release its Q4 and full-year 2023 financial results on February 28, 2024.

At what time will the webcast and conference call to review the results start?

The webcast and conference call to review the results will start at 4:30 p.m. Eastern Time on February 28, 2024.

How can investors access the conference call?

Investors can access the conference call by using the following information: Webcast: Click here, U.S. Investors: 877-407-6184, International Investors: 201-389-0877, Conference ID: 13743067.

Will there be a replay of the webcast available?

Yes, a replay of the webcast will be available for approximately 30 days on MiMedx Group, Inc.'s (MDXG) website at www.mimedx.com following the conclusion of the event.

MiMedx Group, Inc

NASDAQ:MDXG

MDXG Rankings

MDXG Latest News

MDXG Stock Data

1.08B
116.20M
3.76%
61.47%
3.52%
Small Arms, Ordnance, and Ordnance Accessories Manufacturing
Manufacturing
Link
United States of America
MARIETTA

About MDXG

mimedx® is an industry leader in advanced wound care and a therapeutic biologics company developing and distributing human placental tissue allografts with patent-protected processes for multiple sectors of healthcare. the company processes the human placental tissue utilizing its proprietary purion® process methodology, among other processes, to produce allografts by employing aseptic processing techniques in addition to terminal sterilization. mimedx has supplied more than two million allografts, through both direct and consignment shipments. for additional information, please visit www.mimedx.com.